A Randomised Trial of the Effect and Cost-Effectiveness of Early Intensive Mulitfactorial Therapy on 5-Year Cardiovascular Outcomes in Individuals with Screen-Detected Type 2 Diaberes:The Anglod-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) Study., n.d. <http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-64#abstract>
Amori, Renee E., Joseph Lau, and Anastassios G. Pittas, ‘Efficacy and Safety of Incretin Therapy in Type 2 Diabetes’, JAMA, 298.2 (2007), doi:10.1001/jama.298.2.194
Amy Kennedy, ‘Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A Systematic Review and Meta-Analysis’, PLoS ONE, 8.3 (2013), doi:doi: 10.1371/journal.pone.0058861
Anthony H. Barnett, Jenny Grice, New Mechanisms in Glucose Control (BMJ Books; 1 edition, 2013) <http://ezproxy.lib.le.ac.uk/login?url=http://lib.myilibrary.com?id=478133>
‘[ARCHIVED CONTENT] Medicines Management: Everybody’s Business : Department of Health - Publications and Statistics’, n.d. <http://webarchive.nationalarchives.gov.uk/20080205132320/http:/dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_082200>
Atkinson, M. A., ‘The Pathogenesis and Natural History of Type 1 Diabetes’, Cold Spring Harbor Perspectives in Medicine, 2.11 (2012), pp. a007641–a007641, doi:10.1101/cshperspect.a007641
Avery, L., and others, ‘Changing Physical Activity Behavior in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Behavioral Interventions’, Diabetes Care, 35.12 (2012), pp. 2681–89, doi:10.2337/dc11-2452
Bailey, Clifford J., and others, ‘Effect of Dapagliflozin in Patients with Type 2 Diabetes Who Have Inadequate Glycaemic Control with Metformin: A Randomised, Double-Blind, Placebo-Controlled Trial’, The Lancet, 375.9733 (2010), pp. 2223–33, doi:10.1016/S0140-6736(10)60407-2
Bailey, Stephen, Academic Writing : A Handbook for International Students (n.d.) <http://lib.myilibrary.com.ezproxy4.lib.le.ac.uk/Open.aspx?id=310467>
Barry, Vaughn W., and others, ‘Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis’, Progress in Cardiovascular Diseases, 56.4 (2014), pp. 382–90, doi:10.1016/j.pcad.2013.09.002
Bennett, Wendy L., and others, ‘Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations’, Annals of Internal Medicine, 154.9 (2011), doi:10.7326/0003-4819-154-9-201105030-00336
Bergenstal, Richard M., and others, ‘Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes’, New England Journal of Medicine, 363.4 (2010), pp. 311–20, doi:10.1056/NEJMoa1002853
Bethel, M. Angelyn, and others, ‘Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)’, Diabetes Care, 40.4 (2017), pp. 494–501, doi:10.2337/dc16-1135
Beverley M Shields, ‘Can Clinical Features Be Used to Differentiate Type 1 from Type 2 Diabetes? A Systematic Review of the Literature’, BMJ Open, 5.11 (2015), doi:doi: 10.1136/bmjopen-2015-009088
Birkeland, Kåre I., ‘Hyperglycaemia in Pregnancy: Still a Lot to Learn’, The Lancet Diabetes & Endocrinology, 3.10 (2015), pp. 752–53, doi:10.1016/S2213-8587(15)00282-X
Brown, Julie, and others, ‘Lifestyle Interventions for the Treatment of Women with Gestational Diabetes’, in Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd, 1996), doi:10.1002/14651858.CD011970.pub2
Buse, J. B., and others, ‘DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks’, Diabetes Care, 33.6 (2010), pp. 1255–61, doi:10.2337/dc09-1914
Buse, John B., and others, ‘Liraglutide Once a Day versus Exenatide Twice a Day for Type 2 Diabetes: A 26-Week Randomised, Parallel-Group, Multinational, Open-Label Trial (LEAD-6)’, The Lancet, 374.9683 (2009), pp. 39–47, doi:10.1016/S0140-6736(09)60659-0
Buse, John B., and others, ‘Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes’, Annals of Internal Medicine, 154.2 (2011), doi:10.7326/0003-4819-154-2-201101180-00300
Canagliflozin, Dapagliflozin and Empagliflozin as Monotherapies for Treating Type 2 Diabetes | 1-Recommendations | Guidance and Guidelines | NICE, n.d. <https://www.nice.org.uk/guidance/ta390/chapter/1-Recommendations>
Capehorn, M., and others, ‘Challenges Faced by Physicians When Discussing the Type 2 Diabetes Diagnosis with Patients: Insights from a Cross-National Study (IntroDia )’, Diabetic Medicine, published online March 2017, doi:10.1111/dme.13357
Chimen, M., and others, ‘What Are the Health Benefits of Physical Activity in Type 1 Diabetes Mellitus? A Literature Review’, Diabetologia, 55.3 (2012), pp. 542–51, doi:10.1007/s00125-011-2403-2
Choudhary, Pratik, and others, ‘Islet Cell Transplantation: Current Status in the UK (2012)’, Practical Diabetes, 29.7 (2012), pp. 280–85, doi:10.1002/pdi.1707
‘Constructs of Depression and Distress in Diabetes: Time for an Appraisal- ClinicalKey’, n.d. <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858715001357>
‘Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus (Review) TA151, July 2008’, n.d. <http://www.nice.org.uk/guidance/ta151>
Copeland, K. C., and others, ‘Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents’, PEDIATRICS, 131.2 (2013), pp. 364–82, doi:10.1542/peds.2012-3494
Courtney, Hamish, and others, ‘Long-Term Management of Type 2 Diabetes with Glucagon-like Peptide-1 Receptor Agonists’, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 10 (2017), pp. 79–87, doi:10.2147/DMSO.S126763
Creme, Phyllis, and Mary R. Lea, Writing At University: A Guide For Students, 3rd ed (McGraw-Hill Education, 2008) <https://ebookcentral.proquest.com/lib/leicester/detail.action?pq-origsite=primo&docID=345134>
‘Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes June 2013’, n.d. <http://www.nice.org.uk/guidance/ta288>
Davies, M., and others, ‘Introduction of Biosimilar Insulins in Europe’, Diabetic Medicine, 34.10 (2017), pp. 1340–53, doi:10.1111/dme.13400
Davies, M. J., and others, ‘Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) Programme for People with Newly Diagnosed Type 2 Diabetes: Cluster Randomised Controlled Trial’, BMJ, 336.7642 (2008), pp. 491–95, doi:10.1136/bmj.39474.922025.BE
Dhatariya, K. K., C. Skedgel, and R. Fordham, ‘The Cost of Treating Diabetic Ketoacidosis in the UK: A National Survey of Hospital Resource Use’, Diabetic Medicine, 34.10 (2017), pp. 1361–66, doi:10.1111/dme.13427
‘Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period (NG3’, n.d. <https://www.nice.org.uk/guidance/ng3>
Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults | Guidance and Guidelines | NICE, n.d. <https://www.nice.org.uk/guidance/cg15>
Diamant, Michaela, and others, ‘Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-Label Randomised Trial’, The Lancet, 375.9733 (2010), pp. 2234–43, doi:10.1016/S0140-6736(10)60406-0
Dungan, Kathleen M., and others, ‘Once-Weekly Dulaglutide versus Once-Daily Liraglutide in Metformin-Treated Patients with Type 2 Diabetes (AWARD-6): A Randomised, Open-Label, Phase 3, Non-Inferiority Trial’, The Lancet, 384.9951 (2014), pp. 1349–57, doi:10.1016/S0140-6736(14)60976-4
Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Systematic Review and Mixed-Treatment Comparison Analysis, n.d. <http://onlinelibrary.wiley.com.ezproxy3.lib.le.ac.uk/doi/10.1111/dom.12849/epdf>
‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’, New England Journal of Medicine, 375.18 (2016), pp. 1799–802, doi:10.1056/NEJMc1611290
‘Exenatide Prolonged-Release Suspension for Injection in Combination with Oral Antidiabetic Therapy for the Treatment of Type 2 Diabetes | Guidance and Guidelines TA 248 Feb 2015’, n.d. <https://www.nice.org.uk/guidance/ta248>
‘Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring’, Journal of Diabetes Science and Technology (Online), 3.4 (n.d.) <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769951/>
Fagin, James A., and Samuel A. Wells, ‘Biologic and Clinical Perspectives on Thyroid Cancer’, New England Journal of Medicine, 375.11 (2016), pp. 1054–67, doi:10.1056/NEJMra1501993
Ferrari, M., M. Dal Cin, and M. Steele, ‘Self-Compassion Is Associated with Optimum Self-Care Behaviour, Medical Outcomes and Psychological Well-Being in a Cross-Sectional Sample of Adults with Diabetes’, Diabetic Medicine, 34.11 (2017), pp. 1546–53, doi:10.1111/dme.13451
Gale, Edwin AM, ‘Is Type 2 Diabetes a Category Error?’, The Lancet, 381.9881 (2013), pp. 1956–57, doi:10.1016/S0140-6736(12)62207-7
Gallwitz, Baptist, and others, ‘2-Year Efficacy and Safety of Linagliptin Compared with Glimepiride in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Randomised, Double-Blind, Non-Inferiority Trial’, The Lancet, 380.9840 (2012), pp. 475–83, doi:10.1016/S0140-6736(12)60691-6
Grammes, J., and others, ‘Focus Group Study to Identify the Central Facets of Fear of Hypoglycaemia in People with Type 2 Diabetes Mellitus’, Diabetic Medicine, published online 30 August 2017, doi:10.1111/dme.13506
Gray, L. J., and others, ‘External Validation of Two Diabetes Risk Scores in a Young UK South Asian Population’, Diabetes Research and Clinical Practice, 104.3 (2014), pp. 451–58, doi:10.1016/j.diabres.2014.03.018
Gray, L. J., and others, ‘Implementation of the Automated Leicester Practice Risk Score in Two Diabetes Prevention Trials Provides a High Yield of People with Abnormal Glucose Tolerance’, Diabetologia, 55.12 (2012), pp. 3238–44, doi:10.1007/s00125-012-2725-8
Green, Jennifer B., and others, ‘Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 373.3 (2015), pp. 232–42, doi:10.1056/NEJMoa1501352
Gregg, Edward W., ‘The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016’, Diabetes Care, published online 10 August 2017, doi:10.2337/dci16-0055
‘Guidelines’, n.d. <https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes>
Hadjiconstantinou, Michelle, and others, ‘Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis’, Journal of Medical Internet Research, 18.10 (2016), doi:10.2196/jmir.5991
Harman-Boehm, Ilana, ‘Continuous Glucose Monitoring in Type 2 Diabetes’, Diabetes Research and Clinical Practice, 82 (2008), pp. S118–21, doi:10.1016/j.diabres.2008.09.051
Hartman, Yvonne A. W., and others, ‘Insulin-Associated Weight Gain in Type 2 Diabetes Is Associated With Increases in Sedentary Behavior’, Diabetes Care, 40.9 (2017), pp. e120–21, doi:10.2337/dc17-0787
Heinonen, I., and others, ‘Sedentary Behaviours and Obesity in Adults: The Cardiovascular Risk in Young Finns Study’, BMJ Open, 3.6 (2013), doi:10.1136/bmjopen-2013-002901
Henson, Joseph, Associations of Sedentary Time with Fat Distribution in a High-Risk Population., 10 November 2014 <https://lra.le.ac.uk/handle/2381/32505>
Hessler, D. M., and others, ‘Diabetes Distress Is Linked with Worsening Diabetes Management over Time in Adults with Type 1 Diabetes’, Diabetic Medicine, 34.9 (2017), pp. 1228–34, doi:10.1111/dme.13381
Holt, Richard I. G., Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes, 4th ed (Wiley-Blackwell, 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, and others, Textbook of Diabetes, 5th ed (John Wiley & Sons, Incorporated, 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
Inzucchi, Silvio E., and others, ‘Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes’, Diabetes Care, 38.1 (2015), pp. 140–49, doi:10.2337/dc14-2441
Jelinek, Herbert F., and others, ‘Data Analytics Identify Glycated Haemoglobin Co-Markers for Type 2 Diabetes Mellitus Diagnosis’, Computers in Biology and Medicine, 75 (2016), pp. 90–97, doi:10.1016/j.compbiomed.2016.05.005
John M Jakicic, ‘Physical Activity Considerations for the Treatment and Prevention of Obesity’, The American Journal of Clinical Nutrition, 82.1 (2005), pp. 226S-229S <http://ajcn.nutrition.org/content/82/1/226S>
Johnston, Bradley C., and others, ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults’, JAMA, 312.9 (2014), doi:10.1001/jama.2014.10397
Jones, A. G., and A. T. Hattersley, ‘The Clinical Utility of C-Peptide Measurement in the Care of Patients with Diabetes’, Diabetic Medicine, 30.7 (2013), pp. 803–17, doi:10.1111/dme.12159
Kamlesh Khunti, ‘Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes’, PLoS ONE, 10.9 (2015), doi:doi: 10.1371/journal.pone.0135702
Kenneth Hodson, ‘Gestational Diabetes: Emerging Concepts in Pathophysiology’, Obstetric Medicine, 3.4 (2010), doi:doi: 10.1258/om.2010.100025
Latika Sahu, ‘Comparison of the American Diabetes Association and World Health Organization Criteria for Gestational Diabetes Mellitus and the Outcomes of Pregnancy’, Obstetric Medicine, 2.4 (2009), doi:doi: 10.1258/om.2009.080049
Lee, I.-Min, ‘Physical Activity and Weight Gain Prevention’, JAMA, 303.12 (2010), doi:10.1001/jama.2010.312
Leelarathna, L., and others, ‘Comparison of Different Insulin Pump Makes under Routine Care Conditions in Adults with Type 1 Diabetes’, Diabetic Medicine, 34.10 (2017), pp. 1372–79, doi:10.1111/dme.13412
Leff, D. R., and D. Heath, ‘Surgery for Obesity in Adulthood’, BMJ, 339.sep22 1 (2009), pp. b3402–b3402, doi:10.1136/bmj.b3402
Levin, Philip A., and others, ‘Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review of Comparative Effectiveness Research’, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 10 (2017), pp. 123–39, doi:10.2147/DMSO.S130834
‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375.18 (2016), pp. 1797–99, doi:10.1056/NEJMc1611289
‘Liraglutide for the Treatment of Type 2 Diabetes Mellitus. TA203, Oct 2010’, n.d. <https://www.nice.org.uk/guidance/ta203>
——, n.d. <https://www.nice.org.uk/guidance/ta203>
‘Managing Older People with Type 2 Diabetes: IDF Global Guideline - International Federation on Ageing’, n.d. <https://www.ifa-fiv.org/managing-older-people-with-type-2-diabetes-idf-global-guideline/>
Marso, Steven P., and others, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375.4 (2016), pp. 311–22, doi:10.1056/NEJMoa1603827
——, and others, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375.4 (2016), pp. 311–22, doi:10.1056/NEJMoa1603827
——, and others, ‘Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes’, New England Journal of Medicine, published online 15 September 2016, doi:10.1056/NEJMoa1607141
‘Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. CG76, Jan 2009’, n.d. <https://www.nice.org.uk/guidance/cg76>
Merlin C. Thomas, ‘Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment’, Diabetes Therapy, 7.3 (2016), doi:doi: 10.1007/s13300-016-0189-4
Min, Se Hee, and others, ‘Comparison between SGLT2 Inhibitors and DPP4 Inhibitors Added to Insulin Therapy in Type 2 Diabetes: A Systematic Review with Indirect Comparison Meta-Analysis’, Diabetes/Metabolism Research and Reviews, 33.1 (2017), doi:10.1002/dmrr.2818
‘Minimizing Hypoglycemia in Diabetes: Table 1’, Diabetes Care, 38.8 (2015), pp. 1583–91, doi:10.2337/dc15-0279
Mishriky, Basem M., Doyle M. Cummings, and Robert J. Tanenberg, ‘The Efficacy and Safety of DPP4 Inhibitors Compared to Sulfonylureas as Add-on Therapy to Metformin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis’, Diabetes Research and Clinical Practice, 109.2 (2015), pp. 378–88, doi:10.1016/j.diabres.2015.05.025
Moreno-Castilla, Cristina, Didac Mauricio, and Marta Hernandez, ‘Role of Medical Nutrition Therapy in the Management of Gestational Diabetes Mellitus’, Current Diabetes Reports, 16.4 (2016), doi:10.1007/s11892-016-0717-7
Narendran, P., and others, ‘Exercise to Preserve β-Cell Function in Recent-Onset Type 1 Diabetes Mellitus (EXTOD) - a Randomized Controlled Pilot Trial’, Diabetic Medicine, 34.11 (2017), pp. 1521–31, doi:10.1111/dme.13439
‘National Obesity Observatory’, n.d. <http://www.noo.org.uk>
Nauck, M. A., and others, ‘Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Compared with the Sulfonylurea, Glipizide, in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Alone: A Randomized, Double-Blind, Non-Inferiority Trial’, Diabetes, Obesity and Metabolism, 9.2 (2007), pp. 194–205, doi:10.1111/j.1463-1326.2006.00704.x
Nauck, Michael, and others, ‘Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)’, Diabetes Care, 37.8 (2014), pp. 2149–58, doi:10.2337/dc13-2761
Nauck, Michael A., and Juris J. Meier, ‘The Incretin Effect in Healthy Individuals and Those with Type 2 Diabetes: Physiology, Pathophysiology, and Response to Therapeutic Interventions’, The Lancet Diabetes & Endocrinology, 4.6 (2016), pp. 525–36, doi:10.1016/S2213-8587(15)00482-9
NHS Evidence: An Introduction, n.d. <http://www.solent.nhs.uk/_store/documents/nhs_evidence_guide.pdf>
Nissen, Steven E., and Kathy Wolski, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’, New England Journal of Medicine, 356.24 (2007), pp. 2457–71, doi:10.1056/NEJMoa072761
Noctor, Eoin, and Fidelma Dunne, ‘Postnatal Testing Following Gestational Diabetes’, The Lancet Diabetes & Endocrinology, 3.10 (2015), pp. 761–62, doi:10.1016/S2213-8587(15)00322-8
Nolan, Christopher J., and others, ‘Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes’, Diabetes, 64.3 (2015), pp. 673–86, doi:10.2337/db14-0694
Obesity: Identification, Assessment and Management | Guidance and Guidelines | NICE, n.d. <https://www.nice.org.uk/guidance/cg189>
Paul Craddy, ‘Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison’, Diabetes Therapy, 5.1 (2014), doi:doi: 10.1007/s13300-014-0061-3
Perrin, N. E., and others, ‘The Prevalence of Diabetes-Specific Emotional Distress in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis’, Diabetic Medicine, 34.11 (2017), pp. 1508–20, doi:10.1111/dme.13448
Persaud, Shanta J., and Peter M. Jones, ‘A Wake-up Call for Type 2 Diabetes?’, New England Journal of Medicine, 375.11 (2016), pp. 1090–92, doi:10.1056/NEJMcibr1607950
Pickup, John C., ‘Insulin-Pump Therapy for Type 1 Diabetes Mellitus’, New England Journal of Medicine, 366.17 (2012), pp. 1616–24, doi:10.1056/NEJMct1113948
Qin, Li, and others, ‘Does Physical Activity Modify the Risk of Obesity for Type 2 Diabetes: A Review of Epidemiological Data’, European Journal of Epidemiology, 25.1 (2010), pp. 5–12, doi:10.1007/s10654-009-9395-y
Rasouli, B., and others, ‘Serious Life Events and the Risk of Latent Autoimmune Diabetes in Adults (LADA) and Type 2 Diabetes’, Diabetic Medicine, 34.9 (2017), pp. 1259–63, doi:10.1111/dme.13410
Riddle, M. C., and others, ‘Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-Week, Randomized, Placebo-Controlled Comparison (GetGoal-L)’, Diabetes Care, 36.9 (2013), pp. 2489–96, doi:10.2337/dc12-2454
Rinki Murphy, ‘Monogenic Diabetes and Pregnancy’, Obstetric Medicine, 8.3 (2015), doi:doi: 10.1177/1753495X15590713
Rizos, Christos V., Anastazia Kei, and Moses S. Elisaf, ‘The Current Role of Thiazolidinediones in Diabetes Management’, Archives of Toxicology, 90.8 (2016), pp. 1861–81, doi:10.1007/s00204-016-1737-4
Rotz, M. E., and others, ‘Implications of Incretin-Based Therapies on Cardiovascular Disease’, International Journal of Clinical Practice, 69.5 (2015), pp. 531–49, doi:10.1111/ijcp.12572
Ryder, Bob, and others, ‘ABCD Position Statement on GLP-1 Based Therapies and Pancreatic Damage’, Practical Diabetes, 30.9 (2013), pp. 388–91, doi:10.1002/pdi.1816
S M Attard, ‘Implications of Iron Deficiency/Anemia on the Classification of Diabetes Using HbA1c’, Nutrition & Diabetes, 5.6 (2015), doi:doi: 10.1038/nutd.2015.16
Sallis, James F., and others, ‘Progress in Physical Activity over the Olympic Quadrennium’, The Lancet, 388.10051 (2016), pp. 1325–36, doi:10.1016/S0140-6736(16)30581-5
Samuel, Varman T., and Gerald I. Shulman, ‘Intergrating Mechanisms for Insulin Resistance: Common Threads and Missing Links’, Cell, 148.5 (2012), pp. 852–71, doi:10.1016/j.cell.2012.02.017
Schauer, Philip R., and others, ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’, New England Journal of Medicine, 376.7 (2017), pp. 641–51, doi:10.1056/NEJMoa1600869
——, and others, ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’, New England Journal of Medicine, 376.7 (2017), pp. 641–51, doi:10.1056/NEJMoa1600869
——, and others, ‘Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes’, New England Journal of Medicine, 366.17 (2012), pp. 1567–76, doi:10.1056/NEJMoa1200225
Schwartz, Stanley S., and others, ‘The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema’, Diabetes Care, 39.2 (2016), pp. 179–86, doi:10.2337/dc15-1585
Sivasubramaniyam, S., S. A. Amiel, and P. Choudhary, ‘Proportion of Daily Capillary Blood Glucose Readings Required in the Target Range for Target Glycaemic Control: Shift of Focus from Target Range to Proportion in Range’, Diabetic Medicine, 34.10 (2017), pp. 1456–60, doi:10.1111/dme.13438
Sjöström, Lars, and others, ‘Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery’, New England Journal of Medicine, 351.26 (2004), pp. 2683–93, doi:10.1056/NEJMoa035622
Srinivasan, P., and others, ‘Islet Cell Transplantation’, Postgraduate Medical Journal, 83.978 (2007), pp. 224–29, doi:10.1136/pgmj.2006.053447
‘Standards of Medical Care in Diabetes--2015: Summary of Revisions’, Diabetes Care, 38.Supplement_1 (2015), pp. S4–S4, doi:10.2337/dc15-S003
Steven, S., and R. Taylor, ‘Restoring Normoglycaemia by Use of a Very Low Calorie Diet in Long- and Short-Duration Type 2 Diabetes’, Diabetic Medicine, 32.9 (2015), pp. 1149–55, doi:10.1111/dme.12722
Steven, Sarah, and others, ‘Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders’, Diabetes Care, 39.5 (2016), pp. 808–15, doi:10.2337/dc15-1942
Stewart, Zoe A., and others, ‘Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes’, New England Journal of Medicine, 375.7 (2016), pp. 644–54, doi:10.1056/NEJMoa1602494
Tanner, Michael, ‘Review: In Type 2 Diabetes, Adding Dipeptidyl Peptidase-4 Inhibitors to Sulphonylureas Increases Hypoglycemia’, Annals of Internal Medicine, 165.4 (2016), doi:10.7326/ACPJC-2016-165-4-020
Tao, L., and others, ‘Cost-Effectiveness of Intensive Multifactorial Treatment Compared with Routine Care for Individuals with Screen-Detected Type 2 Diabetes: Analysis of the ADDITION-UK Cluster-Randomized Controlled Trial’, Diabetic Medicine, 32.7 (2015), pp. 907–19, doi:10.1111/dme.12711
The Eatwell Guide, (Public Health England, 2016) <https://www.gov.uk/government/publications/the-eatwell-guide>
Type 2 Diabetes in Adults: Management | Guidance and Guidelines | NICE, n.d. <https://www.nice.org.uk/guidance/ng28>
Type 2 Diabetes: Lixisenatide | Evidence-Review | Advice | NICE, n.d. <https://www.nice.org.uk/advice/esnm26/chapter/evidence-review>
Type 2 Diabetes: Prevention in People at High Risk | Guidance and Guidelines | NICE, n.d. <http://www.nice.org.uk/guidance/PH38>
Umpierre, Daniel, ‘Physical Activity Advice Only or Structured Exercise Training and Association With HbA Levels in Type 2 Diabetes’, JAMA, 305.17 (2011), doi:10.1001/jama.2011.576
‘Unit 3 – Special Care Groups: A Practical Guide to Pregnancy Complicated by Diabetes - Diabetes & Primary Care’, n.d. <http://www.diabetesandprimarycare.co.uk/journal-content/view/unit-3-special-care-groups-a-practical-guide-to-pregnancy-complicated-by-diabetes/?preview>
Villani, M., B. de Courten, and S. Zoungas, ‘Emergency Treatment of Hypoglycaemia: A Guideline and Evidence Review’, Diabetic Medicine, 34.9 (2017), pp. 1205–11, doi:10.1111/dme.13379
Vloemans, A. F., and others, ‘Keeping Safe. Continuous Glucose Monitoring (CGM) in Persons with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia: A Qualitative Study’, Diabetic Medicine, 34.10 (2017), pp. 1470–76, doi:10.1111/dme.13429
Wanner, Christoph, and others, ‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’, New England Journal of Medicine, 375.4 (2016), pp. 323–34, doi:10.1056/NEJMoa1515920
William H. Polonsky,Lawrence Fisher,Jay Earles,R. James Dudl,Joel Lees,Joseph Mullan, ‘Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale’, Diabetes Care, n.d. <http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=25&docId=GALE%7CA130282980&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA130282980&searchId=R15&userGroupName=leicester&inPS=true>
Yates, T., and M. J. Davies, ‘Physical Activity and Type 1 Diabetes: An Underused Therapy’, Diabetic Medicine, 34.11 (2017), pp. 1498–99, doi:10.1111/dme.13445
Yeh, James S., Robert F. Kushner, and Gordon D. Schiff, ‘Obesity and Management of Weight Loss’, New England Journal of Medicine, 375.12 (2016), pp. 1187–89, doi:10.1056/NEJMclde1515935
Young-Hyman, Deborah, and others, ‘Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140’, Diabetes Care, 40.2 (2017), p. 287.1-287, doi:10.2337/dc17-er02
Zaccardi, Francesco, and others, ‘Pathophysiology of Type 1 and Type 2 Diabetes Mellitus: A 90-Year Perspective’, Postgraduate Medical Journal, 92.1084 (2016), pp. 63–69, doi:10.1136/postgradmedj-2015-133281
